Literature DB >> 2405313

Tumor markers in gynecologic oncology.

T W Montag1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2405313     DOI： 10.1097/00006254-199002000-00003

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN： 0029-7828            Impact factor:   2.347


× No keyword cloud information.
  5 in total

1.  An Ovarian Cancer Tumor Marker, CA 125, Comes of Age.

Authors:  R E Buller; P J Disaia
Journal:  West J Med       Date:  1990-04

2.  Serum CA 125 levels in patients with non-malignant liver diseases without ascites.

Authors:  J Collazos; J Genolla; M T Allende; A Ruibal
Journal:  Clin Investig       Date:  1993-03

3.  Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix.

Authors:  Ki-Hong Chang; Hee-Sug Ryu; Suk-Joon Chang; Young-Ji Byun; Jung-Pil Lee
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

4.  The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients.

Authors:  Hyun Kyung Ryu; Ji Sun Baek; Woo Dae Kang; Seok Mo Kim
Journal:  Obstet Gynecol Sci       Date:  2015-09-22

5.  GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.

Authors:  Fei Ouyang; Junling Liu; Meng Xia; Chuyong Lin; Xianqiu Wu; Liping Ye; Libing Song; Jun Li; Jing Wang; Peng Guo; Mian He
Journal:  Oncol Rep       Date:  2017-04-11       Impact factor: 3.906
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.